Showing results (241-250 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|January 1, 1997
An in vitro assessment of the antineoplastic potential of 2H-1,3-oxazine-2,6(3H)-dione (3-oxauracil), a novel pyrimidineL Seal, D Von Hoff, R Lawrence, et al.
Investigational New Drugs|January 1, 1997
Potent induction of human colon cancer cell uptake of chemotherapeutic drugs by N-myristoylated protein kinase C-alpha (PKC-alpha) pseudosubstrate peptides through a P-glycoprotein-independent mechanismP J Bergman, K R Gravitt, N E Ward, et al.
Investigational New Drugs|January 1, 1997
Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancerJ J Sharma, B Razvillas, C D Stephens, et al.
Investigational New Drugs|October 31, 2003
Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphismAlbert Font, José Miguel Sánchez, Miquel Tarón, et al.
Investigational New Drugs|July 1, 1992
Toremifene and its metabolites enhance doxorubicin accumulation in estrogen receptor negative multidrug resistant human breast cancer cellsV Wiebe, S Koester, M Lindberg, et al.
Investigational New Drugs|August 1, 1992
Phase I study of mitonafide in 120 hour continuous infusion in non-small cell lung cancerR Rosell, J Carles, A Abad, et al.
Investigational New Drugs|July 1, 1992
Phase II feasibility study of high dose epirubicin plus etoposide and cisplatin (HDEEC) regimen in small cell lung cancerR Rosell, J Carles, A Abad, et al.
Investigational New Drugs|November 1, 1992
Taxol administered as a 120 hour infusionD R Spriggs, C Tondini
Investigational New Drugs|January 7, 2004
Recent advances in brain tumor therapy: local intracerebral drug delivery by polymersChristopher Guerin, Alessandro Olivi, Jon D Weingart, et al.
Investigational New Drugs|January 7, 2004
Phase II study of interferon gamma in malignant carcinoid tumors (E9292): a trial of the Eastern Cooperative Oncology GroupKeith Stuart, Donna E Levy, Tom Anderson, et al.
Pageof 372